Sentinel Bio's Joshua Monrad on DNA screening, uplift studies and agent monitoring
The Cognitive Revolution · rss · 2026-11-06
Sentinel Bio co-founder Joshua Monrad joins The Cognitive Revolution to examine biosecurity risks from frontier AI and autonomous agents. Recent in-lab uplift trials and multimodal troubleshooting benchmarks show emerging models rapidly dismantling tacit-knowledge barriers in wet labs. He analyzes governance interventions from pathogen training-data filtering to DNA synthesis screening and agent monitoring, with robotics as the final physical bottleneck as biological tools move toward dual-use democratization.
More from AGI Musings
- Matthew Berman: Hard to name any AI use case where blindly throwing tokens yields monetary value — MatthewBerman · 2026-11-06
- Anthropic accused of redacting key evidence; researchers say opaque RSI mechanics hinder oversight — Jsevillamol · 2026-11-06
- AI stocks sink as Gary Marcus mocks Musk's 'money won't matter' prophecy — GaryMarcus · 2026-11-06
- Why AI may favor attackers: models ace exploit-finding but are only decent at patching — jessi_cata · 2026-11-06
- Gautam Kamath on AI review: fun science experiment, but false positives can mislead people at scale — thegautamkamath · 2026-11-06
- Alexandr Wang: we're all zombies — AI should be an escalator of human agency — davidsenra · 2026-11-06